Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2600

1.

The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.

Wierońska JM, Sławińska A, Lasoń-Tyburkiewicz M, Gruca P, Papp M, Zorn SH, Doller D, Kłeczek N, Noworyta-Sokołowska K, Gołembiowska K, Pilc A.

Psychopharmacology (Berl). 2014 Jul 11. [Epub ahead of print]

PMID:
25012236
[PubMed - as supplied by publisher]
2.

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in Patients With Schizophrenia.

Stauffer VL, Baygani SK, Kinon BJ, Krikke-Workel JO.

J Clin Psychopharmacol. 2014 Jul 8. [Epub ahead of print]

PMID:
25006819
[PubMed - as supplied by publisher]
3.

Quantitative analyses of schizophrenia-associated metabolites in serum: serum d-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.

Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T.

PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.

PMID:
25004141
[PubMed - in process]
Free Article
4.

The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged.

Veerman SR, Schulte PF, de Haan L.

Pharmacopsychiatry. 2014 Jul 7. [Epub ahead of print]

PMID:
25002292
[PubMed - as supplied by publisher]
5.

Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis.

Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L.

Pharmacopsychiatry. 2014 Jul 7. [Epub ahead of print]

PMID:
25002291
[PubMed - as supplied by publisher]
6.

Glutamate receptors of the delta family are widely expressed in the adult brain.

Hepp R, Audrey Hay Y, Aguado C, Lujan R, Dauphinot L, Potier MC, Nomura S, Poirel O, El Mestikawy S, Lambolez B, Tricoire L.

Brain Struct Funct. 2014 Jul 8. [Epub ahead of print]

PMID:
25001082
[PubMed - as supplied by publisher]
7.

Lower Glutamic Acid Decarboxylase 65-kDa Isoform Messenger RNA and Protein Levels in the Prefrontal Cortex in Schizoaffective Disorder but Not Schizophrenia.

Glausier JR, Kimoto S, Fish KN, Lewis DA.

Biol Psychiatry. 2014 May 29. pii: S0006-3223(14)00371-0. doi: 10.1016/j.biopsych.2014.05.010. [Epub ahead of print]

PMID:
24993056
[PubMed - as supplied by publisher]
8.

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

Rolland B, Jardri R, Amad A, Thomas P, Cottencin O, Bordet R.

Biomed Res Int. 2014;2014:307106. Epub 2014 Jun 4. Review.

PMID:
24991548
[PubMed - as supplied by publisher]
Free PMC Article
9.

Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid.

Bechi B, Amantini D, Tintori C, Botta M, Fabio Rd.

Beilstein J Org Chem. 2014 May 14;10:1114-20. doi: 10.3762/bjoc.10.110. eCollection 2014.

PMID:
24991261
[PubMed]
Free PMC Article
10.

Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: Implications for schizophrenia.

Lin H, Hsu FC, Baumann BH, Coulter DA, Anderson SA, Lynch DR.

Mol Cell Neurosci. 2014 Jun 28. pii: S1044-7431(14)00068-2. doi: 10.1016/j.mcn.2014.06.007. [Epub ahead of print]

PMID:
24983521
[PubMed - as supplied by publisher]
11.

Characterization of Human Hippocampal Neural Stem/Progenitor Cells and Their Application to Physiologically Relevant Assays for Multiple Ionotropic Glutamate Receptors.

Fukushima K, Tabata Y, Imaizumi Y, Kohmura N, Sugawara M, Sawada K, Yamazaki K, Ito M.

J Biomol Screen. 2014 Jun 30. pii: 1087057114541149. [Epub ahead of print]

PMID:
24980597
[PubMed - as supplied by publisher]
12.

Profile of minocycline and its potential in the treatment of schizophrenia.

Zhang L, Zhao J.

Neuropsychiatr Dis Treat. 2014 Jun 17;10:1103-11. doi: 10.2147/NDT.S64236. eCollection 2014. Review.

PMID:
24971013
[PubMed]
Free PMC Article
13.

Targeting of NMDA receptors in new treatments for schizophrenia.

Hashimoto K.

Expert Opin Ther Targets. 2014 Jun 26:1-15. [Epub ahead of print]

PMID:
24965576
[PubMed - as supplied by publisher]
14.

Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3β signaling pathway.

Peng L, Zhang X, Cui X, Zhu D, Wu J, Sun D, Yue Q, Li Z, Liu H, Li G, Zhang J, Xu H, Liu F, Qin C, Li M, Sun J.

Schizophr Res. 2014 Jun 21. pii: S0920-9964(14)00289-8. doi: 10.1016/j.schres.2014.05.037. [Epub ahead of print]

PMID:
24962437
[PubMed - as supplied by publisher]
15.

Activity of D-amino acid oxidase is widespread in the human central nervous system.

Sasabe J, Suzuki M, Imanishi N, Aiso S.

Front Synaptic Neurosci. 2014 Jun 10;6:14. doi: 10.3389/fnsyn.2014.00014. eCollection 2014.

PMID:
24959138
[PubMed]
Free PMC Article
16.

Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia.

Spangaro M, Bosia M, Zanoletti A, Bechi M, Mariachiara B, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R.

Pharmacogenomics. 2014 May;15(7):925-32. doi: 10.2217/pgs.14.42.

PMID:
24956246
[PubMed - in process]
17.

Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway.

Pisar M, Forrest CM, Khalil OS, McNair K, Vincenten MC, Qasem S, Darlington LG, Stone TW.

Brain Res. 2014 Jun 21. pii: S0006-8993(14)00832-4. doi: 10.1016/j.brainres.2014.06.016. [Epub ahead of print]

PMID:
24956103
[PubMed - as supplied by publisher]
18.

Where now for schizophrenia research?

Nutt DJ, Need AC.

Eur Neuropsychopharmacol. 2014 May 28. pii: S0924-977X(14)00150-3. doi: 10.1016/j.euroneuro.2014.05.012. [Epub ahead of print] Review.

PMID:
24950818
[PubMed - as supplied by publisher]
19.

Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.

Matosin N, Fernandez-Enright F, Frank E, Deng C, Wong J, Huang XF, Newell KA.

J Psychiatry Neurosci. 2014 Jun 24;39(4):130242. doi: 10.1503/jpn.130242. [Epub ahead of print]

PMID:
24949866
[PubMed - as supplied by publisher]
Free Article
20.

Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy.

Bernstein HG, Steiner J, Guest PC, Dobrowolny H, Bogerts B.

Schizophr Res. 2014 Jun 16. pii: S0920-9964(14)00253-9. doi: 10.1016/j.schres.2014.03.035. [Epub ahead of print] Review.

PMID:
24948484
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk